Home
Conditions
Pemphigoid, Bullous

Clinical trial condition

Pemphigoid, Bullous

Explore clinical trials studying Pemphigoid, Bullous. Study availability and eligibility vary by location and protocol.

38 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Pemphigoid, Bullous trial results

Completed

Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody

NCT04563923

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: CHU de Nice- Dermatologie Nice, Alpes-Maritimes, France

APHM, Timone Marseille, Bouche Du Rhône, France

APHM, Hôpital Nord Marseille, Bouches du rhône, France

CHU Montpellier, Dermatologie Montpellier, Herault, France

View Trial Details

Completed

Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid

NCT02360202

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: Rouen University Hospital Rouen, France

View Trial Details

Completed

Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid

NCT02226146

Conditions: Autoimmune Diseases, Blister, Immune System Diseases, +6 more
Locations: Research Site Iowa City, Iowa, United States

Research Site Buffalo, New York, United States

Research Site New York, United States

Research Site Durham, North Carolina, United States

View Trial Details

Completed

A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

NCT05267600

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: Investigator site 74 - US0010178 Phoenix, Arizona, United States

Investigator site 6 - US0010138 Fountain Valley, California, United States

Investigator site 121 - US0010092 Redwood City, California, United States

Investigator site 72 - US0010186 Santa Monica, California, United States

View all 129 locations

View Trial Details

Completed

Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.

NCT07188402

Conditions: Autoimmune Diseases, Bullous Pemphigoid (BP), Immune System Diseases, +4 more
Locations: University Rouen Hospital Rouen, France

View Trial Details

Completed

Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid

NCT05984381

Conditions: Autoimmune Diseases, Blister, Bullous Pemphigoid, +7 more
Locations: AIIMS Bhubaneswar Bhubaneswar, Odisha, India

View Trial Details

Completed

rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects

NCT04035733

Conditions: Autoimmune Diseases, Bullous Pemphigoid (BP), Immune System Diseases, +4 more
Locations: University of Lubeck Lübeck, Germany

UMCG Groningen Groningen, Hanzeplein 1, Netherlands

View Trial Details

Completed

JAK Inhibitors' Efficacy in Bullous Pemphigoid

NCT06561256

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Corticosteroids, +6 more
Locations: The First Affiliated Hospital of Fujian Medical University Fujian, Fuzhou, China

View Trial Details

Completed

Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid

NCT02837965

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: Chu Reims Reims, France

View Trial Details

Completed

Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid

NCT05649579

Conditions: Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Pemphigoid, Bullous

Pemphigoid, Bullous trial results

Related conditions